So if you are buying Entest stock on the false notion that they own the license for the Canine endometrial cells, you are fooling yourself ,all they are doing is testing it for Renovocyte , Medistem and renovocyte will be the ones who will profit from the completed trials,not Entest. The only money ENTB will make is if they buy the cells from Renovocyte and sell it to the public in treating dogs, like every other dog hospital will do.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.